Long‐Term Risk of Myocardial Infarction Compared to Recurrent Stroke After Transient Ischemic Attack and Ischemic Stroke: Systematic Review and Meta‐Analysis

Figures

• 

  Figure 1. Evolution of the annual risks of myocardial infarction (MI) and cardiac death in IS/TIA patients over time. The size of the plot is inversely proportional to the within‐study variance. IS indicates ischemic stroke; TIA, transient ischemic attack.

• 

  Figure 2. Evolution of the annual risks of myocardial infarction (MI) and cardiac death in IS/TIA patients with the duration of study follow‐up. The size of the plot is inversely proportional to the within‐study variance. IS indicates ischemic stroke; TIA, transient ischemic attack.

• 

  Figure 3. Evolution of the annual risks of recurrent stroke and vascular death in IS/TIA patients over time. The size of the plot is inversely proportional to the within‐study variance. IS indicates ischemic stroke; TIA, transient ischemic attack.

• 

  Figure 4. Evolution of the annual risks of recurrent stroke and vascular death in IS/TIA patients with the duration of study's follow‐up. The size of the plot is inversely proportional to the within‐study variance. IS indicates ischemic stroke; TIA, transient ischemic attack.

• 

  Figure 5. Evolution of the incidence ratio of fatal and nonfatal myocardial infarction (MI)/recurrent stroke over time and with the duration of study's follow‐up. The size of the plot is inversely proportional to the within‐study variance.

• 

  Figure 6. Evolution of the incidence ratio of cardiac death/fatal recurrent stroke against study's duration of follow‐up and over time. The size of the plot is inversely proportional to the within‐study variance.

• 

  Figure 7. Forest plots of the meta‐analyses of potential risk factors for myocardial infarction (MI) in IS/TIA patients. The size of the square is proportional to the sample size of the study. CAD indicates coronary artery disease; CI, confidence interval; IS, ischemic stroke; M‐H, Mantel‐Haenszel; MI, myocardial infarction; N, number of patients; n, number of studies; P het, P value for heterogeneity; PAD, peripheral artery disease; RR, rate ratio; TIA, transient ischemic attack.